Marilyn J. Manco-Johnson

Overview

Best Publications

• Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

  Marilyn J. Manco-Johnson;Marilyn J. Manco-Johnson;Thomas C. Abshire;Amy D. Shapiro;Brenda Riske

  2218
  Citations

• von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

  W. L. Nichols;M. B. Hultin;A. H. James;M. J. Manco‐Johnson

  1013
  Citations

• Definitions in hemophilia: communication from the SSC of the ISTH.

  V. S. Blanchette;N. S. Key;Rolf Ljung;M. J. Manco-Johnson

  697
  Citations

• A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

  Bray Gl;Gomperts Ed;Courter S;Gruppo R

  508
  Citations

• A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

  Flora Peyvandi;Pier M Mannucci;Isabella Garagiola;Amal El-Beshlawy

  505
  Citations

• Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

  Jerry S. Powell;K. John Pasi;Margaret V. Ragni;Margareth C. Ozelo

  378
  Citations

• Hemophilia joint health score reliability study

  P. Hilliard;S. Funk;N. Zourikian;B.-M. Bergstrom

  375
  Citations

• Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children A Systematic Review and Meta-Analysis of Observational Studies

  Gili Kenet;Lisa K. Lütkhoff;Manuela Albisetti;Timothy Bernard

  361
  Citations

• Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score.

  Brian M. Feldman;Sharon M. Funk;Britt‐Marie Bergstrom;Nichan Zourikian

  311
  Citations

• Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children

  Neil A. Goldenberg;R. Knapp-Clevenger;Marilyn J. Manco-Johnson

  305
  Citations

• Impact of Inherited Thrombophilia on Venous Thromboembolism in Children A Systematic Review and Meta-Analysis of Observational Studies

  Guy Young;Manuela Albisetti;Mariana Bonduel;Leonardo Brandao

  301
  Citations

• Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.

  Sandra L. Haberichter;Michael Balistreri;Pamela Christopherson;Patricia Morateck

  297
  Citations

• Consensus perspectives on prophylactic therapy for haemophilia: summary statement.

  Erik Berntorp;Jan Astermark;S Björkman;V. S. Blanchette

  293
  Citations

• Barriers to compliance with prophylaxis therapy in haemophilia

  M R Hacker;S Geraghty;M Manco-Johnson

  285
  Citations

• Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART).

  M. J. Manco-Johnson;C. L. Kempton;M. T. Reding;T. Lissitchkov

  241
  Citations

• Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis

  Marilyn J. Manco-Johnson;Rachelle Nuss;Nigel Key;Christopher Moertel

  236
  Citations

• Protein C deficiency.

  N. A. Goldenberg;Marilyn J. Manco-johnson

  233
  Citations

• End-stage liver disease in persons with hemophilia and transfusion-associated infections.

  James J. Goedert;M. Elaine Eyster;Michael M. Lederman;Titica Mandalaki

  230
  Citations

• Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors

  Neil A. Goldenberg;Marco P. Donadini;Susan R. Kahn;Mark Crowther

  229
  Citations

• Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.

  Chengwen Li;N. Narkbunnam;N. Narkbunnam;Richard J Samulski;Aravind Asokan

  216
  Citations